Skip to main
AMTX
AMTX logo

Aemetis (AMTX) Stock Forecast & Price Target

Aemetis (AMTX) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Aemetis Inc. is poised for significant revenue growth, with projections indicating an increase from $398 million in 2025 to $1.8 billion by 2036, reflecting a compound annual growth rate (CAGR) of approximately 14.4%. The company's strategic focus on diversifying its offerings, including cash flows from renewable natural gas (RNG) and potential proceeds from an initial public offering (IPO) of its biodiesel business in 2025, may substantially enhance its balance sheet. Additionally, the expected rebound of Aemetis' India operations with new contracts in the current first quarter further strengthens the outlook for continued operational success and financial stability in the upcoming years.

Bears say

Aemetis Inc. faced significant challenges in its financial performance, with a drastic decline in revenues from its India segment, which dropped from $32 million in Q3 2024 to only $3 million in Q4. The company reported a net loss of $16.2 million for Q4 2024, translating to a loss of $0.36 per share, which, while an improvement from the $25.4 million loss and $0.64 per share in the same quarter the previous year, still fell short of estimates. Overall, these financial indicators reflect ongoing operational difficulties and market challenges that contribute to a negative outlook for Aemetis's stock.

Aemetis (AMTX) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aemetis and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aemetis (AMTX) Forecast

Analysts have given Aemetis (AMTX) a Buy based on their latest research and market trends.

According to 8 analysts, Aemetis (AMTX) has a Buy consensus rating as of Jul 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aemetis (AMTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.